X4 Pharmaceuticals, Inc.
USD3.63
-0.06 (-1.49%)
CEO
Adam R. Craig
IPO Date
2017-11-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.68
Prev. Close
$3.68
Day Low
$3.63
Day High
$3.77
52W Low
$1.35
52W High
$4.83
Market Cap
$0.34B
Volume
0.16M
| 110,000 |
| $4.08 |
| 1 Jul 2026 | Gold Kelly | director: | Disposed | 0 | $0.00 |
| 13 May 2026 | KIRSKE DAVID | Chief Financial Officer | S-Sale | Disposed | 16,961 | $4.29 |
| 7 Jan 2026 | Bridger Gary | director | A-Award | Acquired | 110,000 | $4.00 |
| 5 Jan 2026 | de Craecker Francoise | director | A-Award | Acquired | 110,000 | $4.00 |
| 5 Jan 2026 | WYZGA MICHAEL S | director | A-Award | Acquired | 110,000 | $4.00 |
| 5 Jan 2026 | Stewart Murray | director | A-Award | Acquired | 110,000 | $4.00 |
| 31 Oct 2025 | Craig Adam R | director, officer: Executive Chairman | A-Award | Acquired | 2,329,154 | $1.42 |
| 31 Oct 2025 | Volpone John | President | A-Award | Acquired | 2,329,154 | $1.42 |